Skip to content

Nivea's parent Beiersdorf faces investor doubts as stock plummets 20% in 2024

A once-dominant skincare giant now fights for survival. Can Beiersdorf's bold product push save Nivea—or is the damage already done?

The image shows a paper with text and pictures advertising Kelly's Quality Nursery Stock at lowest...
The image shows a paper with text and pictures advertising Kelly's Quality Nursery Stock at lowest prices in years.

Nivea's parent Beiersdorf faces investor doubts as stock plummets 20% in 2024

Beiersdorf's Latest Figures Disappoint—Especially for Nivea

Beiersdorf's most recent financial results have left much to be desired, particularly when it comes to its flagship brand, Nivea. The company is now pushing for a turnaround, with plans that include a major product offensive. Analysts, however, remain unconvinced.

Doubts Over a Quick Recovery

Among the skeptics is US investment bank Morgan Stanley, which argues that reviving Nivea will be neither easy nor swift. Given the challenges ahead, the firm sees downside risks outweighing potential gains in the sector. As a result, it has downgraded Beiersdorf's stock rating from a neutral "Equal-Weight" to a bearish "Underweight."

Deeper into the Red

At the same time, market professionals have slashed their price target for the stock from €84 to €77—a move that has done little to bolster the dwindling confidence of the few remaining bulls. The downward spiral continued this week, with only a minor rebound on Friday, driven more by broader market sentiment than any real improvement in fundamentals.

By mid-morning, shares were trading at a modest €73.32, down more than 5% from the previous week. Since the start of the year, the stock has plunged over 20%, a stark vote of no confidence from investors who increasingly doubt Nivea—and Beiersdorf's—chances of a strong comeback.

Beiersdorf: No Clear Signals for Recovery

The company's outlook is worsening as rising oil prices drive up costs. Passing those expenses on to consumers risks shrinking sales, while absorbing them could erode margins—setting the stage for another unpleasant surprise in future earnings reports. For now, there's no easy way out of this dilemma.

Read also:

Latest